"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
| Descriptor ID |
D015534
|
| MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
| Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 5 | 2 | 7 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 2 | 3 |
| 1999 | 4 | 0 | 4 |
| 2000 | 5 | 2 | 7 |
| 2001 | 2 | 1 | 3 |
| 2002 | 5 | 1 | 6 |
| 2003 | 7 | 3 | 10 |
| 2004 | 8 | 3 | 11 |
| 2005 | 6 | 3 | 9 |
| 2006 | 1 | 3 | 4 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 4 | 5 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 2 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors. J Cutan Pathol. 2021 Sep; 48(9):1139-1149.
-
?Np63-Regulated Epithelial-to-Mesenchymal Transition State Heterogeneity Confers a Leader-Follower Relationship That Drives Collective Invasion. Cancer Res. 2020 09 15; 80(18):3933-3944.
-
The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex. J Biol Chem. 2020 02 28; 295(9):2698-2712.
-
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells. Cell Commun Signal. 2019 02 19; 17(1):13.
-
Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Genes Immun. 2019 04; 20(4):281-292.
-
Nephron progenitor cell death elicits a limited compensatory response associated with interstitial expansion in the neonatal kidney. Dis Model Mech. 2018 Jan 29; 11(1).
-
BRG1 (Brahma-Related Gene 1) Promotes Endothelial Mrtf Transcription to Establish Embryonic Capillary Integrity. Arterioscler Thromb Vasc Biol. 2017 09; 37(9):1674-1682.
-
Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression. Mol Pharmacol. 2017 09; 92(3):366-374.
-
POU2AF1 Functions in the Human Airway Epithelium To Regulate Expression of Host Defense Genes. J Immunol. 2016 Apr 01; 196(7):3159-67.
-
Tolerance of DNA Mismatches in Dmc1 Recombinase-mediated DNA Strand Exchange. J Biol Chem. 2016 Mar 04; 291(10):4928-38.